# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-20-010264
Filing Date
2020-10-14
Accepted
2020-10-14 17:24:15
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 2766821
2 | GRAPHIC | g25824g02v27.jpg | GRAPHIC | 307253
3 | GRAPHIC | g25824g44y28.jpg | GRAPHIC | 32301
4 | GRAPHIC | g25824g74l38.jpg | GRAPHIC | 87205
5 | GRAPHIC | g25824g86y12.jpg | GRAPHIC | 86273
6 | GRAPHIC | g25824g88u37.jpg | GRAPHIC | 80007
7 | GRAPHIC | g25824g89o56.jpg | GRAPHIC | 45277
8 | GRAPHIC | g25824g90w25.jpg | GRAPHIC | 77748
| Complete submission text file | 0000950123-20-010264.txt |  | 3739155

Mailing Address DARWINWEG 24 LEIDEN P7 2333 CR
Business Address DARWINWEG 24 LEIDEN P7 2333 CR 31 (0)71 5247 400
Pharming Group N.V. (Filer) CIK: 0001828316 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03667 | Film No.: 201239675
SIC: 2834 Pharmaceutical Preparations